Slow progressive neurocognitive impairment with Parkinsonism: A rare, adult-onset Neuronal Intranuclear Inclusion disease (NIID) case report
Objective: We described a case of a 62-years old lady with underlying diabetes and hypertension, presented with right upper intermittent resting tremor and stiffness for…Clinical and radiological factors associated with mortality in Parkinson’s disease
Objective: To assess clinical and radiological risk factors of mortality in a cohort of patients with a clinical diagnosis of Parkinson’s disease (PD) according to…Estrogen derivatives and hydrogen peroxide as promising biomarkers in parkinson’s disease-preliminary results
Objective: The study aimed to identify biomarkers of early-stage neurodegeneration in Parkinson’s disease (PD). Background: The currently available diagnostic clinical criteria for PD enable diagnosis…SLP-2 modulated expression rescues mitochondrial function in alpha-synuclein neuropathology models
Objective: Validate the rescue potential of SLP-2 induction for α-synuclein (aSyn)-induced mitochondrial pathology and neurodegeneration in two complementary models: human induced pluripotent stem cell (hiPSC)-derived…Exploring patient-physician communication in Parkinson’s disease management: a qualitative analysis
Objective: To explore the unmet needs in patient-physician communication from different perspective.To explore the unmet needs in patient-physician communication from different perspective. Background: Patient-physician communication…turning alterations detected by mobile health technology in idiopathic rem sleep behavioral disorders
Objective: Aim of the study was to evaluate subtle alterations of turning in iRBD subjects in absence of parkinsonism using Mobile health technology (MHT). Background:…In vivo proteomic investigation of deeply phenotyped parkinsonian syndromes for biomarkers of differential diagnosis
Objective: To investigate deeply-phenotyped cohorts of parkinsonian syndromes using proteomic technologies for identification of biomarkers for differential diagnosis Background: Proteomic technologies like Olink® Explore 3072…15-year effects of initiating treatment for Parkinson’s disease with dopamine agonists or monoamine oxidase B inhibitors compared with levodopa: final results of PD MED early disease randomisation
Objective: PD MED EARLY is a large, pragmatic trial aiming to determine which class of drug as initial treatment provides the most effective long-term control…Evaluation of structural brain stem measurements for the differential diagnosis of MSA and IPD
Objective: To evaluate structural brain stem measurements to differentiate multiple system atrophy (MSA) from idiopathic Parkinson‘s disease (IPD). Background: MSA is a sporadic, progressive, neurodegenerative…Local field potentials in the subthalamic nucleus of patients with Parkinson’s disease – Effect of the deep brain stimulation
Objective: To obtain knowledge that would lead to the usage of local field potentials (LFP) in the deep brain stimulation therapy (DBS). Background: The LFP…
- « Previous Page
- 1
- …
- 609
- 610
- 611
- 612
- 613
- …
- 1942
- Next Page »